Biogen

TYSABRI

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TYSABRI – J2323

Manufacturer:

Biogen

Name:

TYSABRI

HCPCS Code Descriptor:

Injection, natalizumab, 1 mg

Category:

J Code

HCPCS:

J2323

NDC(s):

64406-0008-01

Primary Type:

Neurology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TYSABRI is a Neurology drug manufactured by Biogen and administered via the Intravenous route of administration. The J Code: J2323 is aligned to the drug TYSABRI.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/08

HCPCS Effective Date:

1/1/08

HCPCS Short Description:

Natalizumab injection

Billing and Coding Guide:

https://www.tysabrihcp.com/content/dam/commercial/tysabri/hcp/en_us/pdf/tysabri-hcp-access-and-reimbursement-guide-electronic.pdf

Patient Assistance:

https://www.biogen.com/en_us/financial-assistance.html